Intech Biopharm Corporation (6461.TWO)
TWD 26.4
(-1.31%)
TWD 26.4
(-1.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 25.84 Million | 23.64 Million | 38.89 Million | 21.1 Million | - |
| Cost of Revenue | 189.84 Million | 170.9 Million | 158.26 Million | 159.99 Million | - |
| Gross Profit | -163.99 Million | -147.26 Million | -119.37 Million | -138.89 Million | - |
| Operating Expenses | -163.99 Million | 170.81 Million | 174.61 Million | 101.67 Million | - |
| Selling, General and Administrative Expenses | 51.98 Million | 52.14 Million | 47.98 Million | 39.34 Million | - |
| Research and Development Expenses | 104.48 Million | 118.67 Million | 126.63 Million | 62.32 Million | - |
| Other Expenses | - | 11.31 Million | 10.91 Million | 6.28 Million | - |
| Cost and Expenses | 346.31 Million | 341.72 Million | 332.88 Million | 261.66 Million | - |
| Operating Income | -304.39 Million | -304.83 Million | -282.21 Million | -233.55 Million | - |
| Interest Expense | 33.59 Million | 23.04 Million | 19.54 Million | 16.81 Million | 19.31 Million |
| Income Tax Expense | - | - | - | - | - |
| Earnings before Tax | -337.98 Million | -327.87 Million | -301.75 Million | -250.37 Million | - |
| Net Income | -337.98 Million | -327.87 Million | -301.75 Million | -250.37 Million | - |
| Earnings Per Share Basic | -2.81 | -2.82 | -2.89 | -2.42 | - |
| Earnings Per Share Diluted | -2.81 | -2.82 | -2.89 | -2.42 | - |
| Weighted Average Shares Outstanding | 120.46 Million | 116.13 Million | 104.4 Million | 103.51 Million | 103.51 Million |
| Weighted Average Shares Outstanding (Diluted) | 120.46 Million | 116.13 Million | 104.4 Million | 103.51 Million | 103.51 Million |
| Gross Margin | -6.34 | -6.23 | -3.07 | -6.58 | - |
| EBIT Margin | -8.50 | -9.28 | -5.06 | -7.04 | - |
| Profit Margin | -13.08 | -13.87 | -7.76 | -11.86 | - |
| EBITDA | -219.58 Million | -219.48 Million | -197.4 Million | -148.61 Million | -217.64 Million |
| Earnings Before Tax Margin | -11.78 | -12.89 | -7.26 | -11.07 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 5.2 Million | 14.76 Million | 5.44 Million | 25.84 Million | 6.86 Million | 9.89 Million |
| Cost of Revenue | 46.54 Million | 47.87 Million | 48.65 Million | 189.84 Million | 50.34 Million | 47.58 Million |
| Gross Profit | -41.33 Million | -33.1 Million | -43.21 Million | -163.99 Million | -43.48 Million | -37.69 Million |
| Operating Expenses | 47.34 Million | 38.19 Million | 51.08 Million | 156.47 Million | 37.2 Million | 31.13 Million |
| Selling, General and Administrative Expenses | 12.48 Million | 11.76 Million | 18.99 Million | - | 10.76 Million | 11.55 Million |
| Research and Development Expenses | 34.85 Million | 26.43 Million | 32.09 Million | - | 26.44 Million | 19.58 Million |
| Other Expenses | 2.77 Million | 3.38 Million | 2.85 Million | 11.65 Million | 2.61 Million | 3.39 Million |
| Cost and Expenses | 93.88 Million | 86.06 Million | 99.73 Million | 346.31 Million | 87.55 Million | 78.72 Million |
| Operating Income | -84.07 Million | -66.29 Million | -89.69 Million | -304.39 Million | -77.28 Million | -64.36 Million |
| Interest Expense | 8.54 Million | 8.6 Million | 8.5 Million | 33.59 Million | 8.58 Million | 8.41 Million |
| Income Tax Expense | - | - | - | - | - | - |
| Earnings before Tax | -92.62 Million | -74.9 Million | -98.19 Million | -337.98 Million | -85.86 Million | -72.77 Million |
| Net Income | -92.62 Million | -74.9 Million | -98.19 Million | -337.98 Million | -85.86 Million | -72.77 Million |
| Earnings Per Share Basic | -0.68 | -0.55 | -0.77 | - | -0.73 | -0.60 |
| Earnings Per Share Diluted | -0.68 | -0.55 | -0.77 | - | -0.73 | -0.60 |
| Weighted Average Shares Outstanding | 136.2 Million | 136.18 Million | 128.32 Million | 120.46 Million | 117.61 Million | 120.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 136.2 Million | 136.18 Million | 128.32 Million | 120.46 Million | 117.61 Million | 120.45 Million |
| Gross Margin | -7.94 | -2.24 | -7.94 | -6.34 | -6.34 | -3.81 |
| EBIT Margin | -11.91 | -3.04 | -12.59 | - | -8.19 | -4.35 |
| Profit Margin | -17.79 | -5.07 | -18.04 | -13.08 | -12.51 | -7.35 |
| EBITDA | -62 Million | -44.94 Million | -68.54 Million | - | -56.16 Million | -43.05 Million |
| Earnings Before Tax Margin | -16.15 | -4.49 | -16.48 | -11.78 | -11.26 | -6.50 |
TR1
BIG
PECO
CDAB
6197
1223